Context Therapeutics Inc. (CNTX) Social Stream

Context Therapeutics Inc. (CNTX): $2.00

-0.06 (-2.91%)

POWR Rating

Component Grades













Add CNTX to Watchlist
Sign Up

Industry: Biotech


of 400

in industry

Context Therapeutics Inc (CNTX) Price Targets From Analysts

Use the tables below to see what analysts covering Context Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-24 1 $10 $10 $10 $2.4 316.67%
2022-03-24 2 $10 $6 $8 $2.4 233.33%
NA 1 $NA $NA $NA $2.4 NA%

Over the past 59 days, CNTX's average upside potential has been 295.28%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-24 2 10 10 10 2.24 346.43%
2022-01-24 1 10 10 10 2.24 346.43%
2022-02-02 2 10 6 8 2.35 240.43%
2022-03-24 2 10 6 8 2.30 247.83%

CNTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how Context Therapeutics Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than 9.42% of that group.
  • Context Therapeutics Inc's average analyst price target is higher than 23.53% of all US stocks.
  • In the context of stocks in the micro market cap category, Context Therapeutics Inc's variance in analysts' estimates is lower than 29.86% of them.
  • CNTX has a greater upside potential (average analyst target price relative to current price) than 212.27% of Healthcare stocks.

In the Pharmaceutical Products industry, CNSP, CLSN, and CLRB are the three stocks most similar to Context Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is CNTX a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4523 seconds.